Cargando…
Ceftriaxone/dexamethasone/tocilizumab: Meningitis and spesis due to streptococcus pneumoniae infection and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948038/ http://dx.doi.org/10.1007/s40278-022-12101-5 |
Ejemplares similares
-
Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022) -
Rare but not forgotten: A case of meningitis due to ceftriaxone-resistant Streptococcus pneumoniae
por: Hauser, Naomi, et al.
Publicado: (2018) -
Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021) -
Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Ceftriaxone: Lack of efficacy: case report
Publicado: (2022)